Evidence map›Paper›PMID 34292886›Full record

ArticleThe Journal of clinical investigation2021

Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models.

Nathan D Winters, Gaurav Bedse, Anastasia A Astafyev, Toni A Patrick, Megan Altemus, Amanda J Morgan, Snigdha Mukerjee, Keenan D Johnson, Vikrant R Mahajan, Md Jashim Uddin and 7 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. An Amygdala-hippocampus Circuit for Endocannabinoid Modulation of Anxiety Avoidance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 3 countries.

Nathan D WintersDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States of America.
Gaurav BedseDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Anastasia A AstafyevDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Toni A PatrickDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Megan AltemusDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Amanda J MorganDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Snigdha MukerjeeDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States of America.
Keenan D JohnsonDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Vikrant R MahajanDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Md Jashim UddinDepartment Biochemistry and Chemistry, Vanderbilt University School of Medicine, Nashville, United States of America.
Philip J KingsleyDepartment Biochemistry and Chemistry, Vanderbilt University School of Medicine, Nashville, United States of America.
Samuel W CentanniDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States of America.
Cody A SicilianoDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States of America.
David C SamuelsDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, China.
Lawrence J MarnettDepartment Biochemistry and Chemistry, Vanderbilt University School of Medicine, Nashville, United States of America.
Danny G WinderDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States of America.
Sachin PatelDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, United States of America.
Vanderbilt University · USAllen Institute for Brain Science · US

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Alcohol action on extended amygdala glutamate synapsesR37AA019455 · NIAAA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2015 to 2024
$3.9M
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use DisordersR01AA026186 · NIAAA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Sachin Patel · 2017 to 2026
$3.5M
Alcohol action on extended amygdala glutamate synapsesR01AA019455 · NIAAA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2010 to 2014
$1.8M
NIAAA NIH HHS R01 AA019455NIAAA NIH HHS R01 AA026186NIAAA NIH HHS R37 AA019455NICHD NIH HHS P50 HD103537
6 · The paper itself

Abstract

Alcohol use disorder (AUD) is associated with substantial morbidity, mortality, and societal cost, and pharmacological treatment options for AUD are limited. The endogenous cannabinoid (eCB) signaling system is critically involved in reward processing and alcohol intake is positively correlated with release of the eCB ligand 2-Arachidonoylglycerol (2-AG) within reward neurocircuitry. Here we show that genetic and pharmacological inhibition of diacylglycerol lipase (DAGL), the rate limiting enzyme in the synthesis of 2-AG, reduces alcohol consumption in a variety of preclinical models ranging from a voluntary free-access model to aversion resistant-drinking and dependence-like drinking induced via chronic intermittent ethanol vapor exposure in mice. DAGL inhibition during either chronic alcohol consumption or protracted withdrawal was devoid of anxiogenic and depressive-like behavioral effects. Lastly, DAGL inhibition also prevented ethanol-induced suppression of GABAergic transmission onto midbrain dopamine neurons, providing mechanistic insight into how DAGL inhibition could affect alcohol reward. These data suggest reducing 2-AG signaling via inhibition of DAGL could represent an effective approach to reduce alcohol consumption across the spectrum of AUD severity.

Indexed as

AddictionBehaviorNeuroscienceTherapeutics

Identifiers

PMID34292886
PMCPMC8409586
OpenAlexW3186480625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.